A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis

Clin Lung Cancer. 2024 Jan 30:S1525-7304(24)00011-1. doi: 10.1016/j.cllc.2024.01.008. Online ahead of print.
No abstract available

Keywords: Bypass track resistance; Cutaneous eruption; Lung adenocarcinoma; Oncogenic driver mutations; ROS1 tyrosine kinase inhibitor.

Publication types

  • Case Reports